2-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 95.0%, 1g

GC capillary column ROTI®Cap-1, 20 m, 0.10 mm, 0.10 µm, 1 Piece(s)

2,6-Dichloro-4-(trifluoromethoxy)aniline>98.0%(GC)5g

5-Hydroxyanthranilic acid, 98.0%, 25g

N,N'-Bis(2,2,6,6-tetramethylpiperidin-4-yl)hexane-1,6-diamine, 98%, 25g

Plan PLi 10x/0.25 infinity corrected IOS objective. Working distance 5.0 mm

2-Methoxy-4-methyl-3-nitropyridine, 97.0%, 250mg

1,6,7,12-Tetrachloroperylenetetracarboxylic acid dianhydride, 95.0%, 25g

Ethyl 5-amino-1-(2-bromophenyl)-1H-pyrazole-3-carboxylate, 95.0%, 100mg

5-(TRIFLUOROMETHYL)-1H-1,2,3-TRIAZOLE-4-CARBOXYLIC ACID, 95.0%, 500mg

4-Hydroxyphenylboronic acid, 98.0%, 1kg

1,4-Diisocyanatocyclohexane (cis- and trans- mixture)>98.0%(GC)1g

2-Bromo-3,4-dichloroaniline, 98%, 1g